Stock listing
Reprocell Inc.
Selected listing: 4978 · TSE · JPY · JP
Reprocell Inc. (Tokyo:4978), Health Technology. Latest release Mar 3, 2026: REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs.
- Ticker
- Tokyo:4978
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Tokyo
- Currency
- JPY
About Reprocell Inc.
The company specializes in advanced technologies for regenerative medicine and stem cell research. Reprocell aims to provide innovative solutions to support scientific advancements in healthcare.
Latest news from Reprocell Inc.
REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs
March 3, 2026
ReproCELL Incorporated : Notice Regarding the Launch of "Middle Conditioning Program," a New Service Under the Healthcare Brand "WELLMILL"
January 27, 2026
ReproCELL Incorporated : Notice Regarding the Launch of "Genetic Age Measurement Kit," a New Service to Scientifically Visualize Biological Age
January 26, 2026
ReproCELL Incorporated : Announces the Commercial Launch of its StemEdit Hypoimmune hiPSC Lines Generated with Advanced Gene Editing Innovations
November 7, 2025
ReproCELL Incorporated : How Human Tissue Testing Adds Commercial Value for Shareholders
September 3, 2025